LumiThera Closes Series C Round of Financing

SEATTLE, July 8, 2020 -- (Healthcare Sales & Marketing Network) -- LumiThera Inc., a commercial stage private medical device company, creating a multi-wavelength photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has ... Devices, Ophthalmology, Venture Capital LumiThera , photobiomodulation, Diabetic Retinopathy

Source: HSMN NewsFeed - July 8, 2020 Category: Pharmaceuticals Source Type: news